Follow us on:

Zoetic International setting up for a very bright future (Interview)

Zoetic International plc (LON:ZOE) Co-CEO Trevor Taylor joins DirectorsTalk to discuss it hemp seed activities. Trevor explains what it hopes to achieve through its partnership with GVB Biopharma, the termination of a lease on its Colorado greenhouse facility and an agreement with a European cultivation partner and whether the changes have altered the focus of Zoetic.

Zoetic International is a vertically integrated CBD company, listed on the London stock exchange. It is headquartered in Colorado and retails products on both sides of the Atlantic.

Find more news, interviews, share price & company profile here for:

Share this interview

Other Interviews

More News

Zoetic International 2020 was hugely significant period January 28, 2021
Zoetic International begins trading on OTCQX® Best Market January 8, 2021
Zoetic International landmark agreement to distribute products across tens of thousands of US retail stores November 24, 2020
Zoetic International roll out of products ahead of schedule with overwhelmingly positive response November 19, 2020
Zoetic International update on sale of DTU and Kansas Nitrogen Assets November 5, 2020
Zoetic International receives significant order to roll out Chill range of tobacco-substitute CBD products October 28, 2020
Zoetic International shareholders encouraged to vote by proxy for AGM October 2, 2020
Zoetic International consistent increased sales of CHILL, month on month September 30, 2020
Zoetic International signs its second international distribution contract September 10, 2020
Zoetic International partner with cannabinoid research experts GVB Biopharma July 22, 2020

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.